Pneumococci causing invasive disease in children prior to the introduction of pneumococcal conjugate vaccine in Scotland

被引:7
|
作者
Clarke, Stuart C.
Jefferies, Johanna M. C.
Smith, Andrew J.
McMenamin, Jim
Mitchell, Timothy J.
Edwards, Giles F. S.
机构
[1] Stobhill Gen Hosp, Scottish Meningococcus & Pneumococcus Reference L, Glasgow G21 3UW, Lanark, Scotland
[2] Univ Glasgow, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow G12 8QQ, Lanark, Scotland
[3] Portsmouth City Teaching PCT, Portsmouth PO3 6DP, Hants, England
[4] Glasgow Dent Hosp & Sch, Glasgow G2 3JZ, Lanark, Scotland
[5] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland
关键词
D O I
10.1099/jmm.0.46550-0
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study aimed to determine the serotypes and sequence types (STs) of pneumococci causing paediatric invasive disease in Scotland prior to the introduction of pneumococcal conjugate vaccines (PCVs). All invasive pneumococci isolated between 2000 and 2004 from children aged less than 5 years in Scotland were used. The isolates were characterized by serotyping and multi-locus sequence typing. Two hundred and seventeen pneumococci were characterized into 22 different serogroups/types, the most common, in rank order, being 14, 19F, 6B, 18C, 23F, 9V, 4, 1, 19A and 6A. They were further genotyped into 77 different STs, the three most common being 9, 162 and 176. Common serotypes possessed multiple STs, but pneumococci of a particular clone were mostly associated with a particular serotype. The seven most common serotypes are included in the 7-valent polysaccharide conjugate vaccine (PCV7). Serotype coverage for PCV7 was 76.5 % in those aged less than 5 years but increased to 88.9 % for those aged 1 year. The introduction of PCV7 into the childhood immunization schedule would reduce the burden of pneumococcal disease in children, although continued surveillance of invasive pneumococcal disease will be required before, during and after the introduction of PCVs.
引用
收藏
页码:1079 / 1084
页数:6
相关论文
共 50 条
  • [41] Vaccine-preventable disease incidence of pneumococcal conjugate vaccine in the Finnish invasive pneumococcal disease vaccine trial
    Palmu, Arto A.
    Jokinen, Jukka
    Nieminen, Heta
    Rinta-Kokko, Hanna
    Ruokokoski, Esa
    Puumalainen, Taneli
    Moreira, Marta
    Schuerman, Lode
    Borys, Dorota
    Kilpi, Terhi M.
    VACCINE, 2018, 36 (14) : 1816 - 1822
  • [42] Invasive pneumococci before the introduction of pneumococcal conjugate vaccine in Turkey: antimicrobial susceptibility, serotype distribution, and molecular identification of macrolide resistance
    Altun, Hatice Uludag
    Hascelik, Gulsen
    Gur, Deniz
    Eser, Ozgen Koseoglu
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (02) : 74 - 79
  • [43] Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
    Knol, Mirjam J.
    Wagenvoort, Gertjan H. J.
    Sanders, Elisabeth A. M.
    Elberse, Karin
    Vlaminckx, Bart J.
    de Melker, Hester E.
    van der Ende, Arie
    EMERGING INFECTIOUS DISEASES, 2015, 21 (11) : 2040 - 2044
  • [44] Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine
    Obando, I.
    Arroyo, L. A.
    Sanchez-Tatay, D.
    Tarrago, D.
    Moreno, D.
    Hausdorff, W. P.
    Brueggemann, A. B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (03) : 347 - 348
  • [45] Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era
    Olarte, Liset
    Lin, Philana Ling
    Barson, William J.
    Romero, Jose R.
    Tan, Tina Q.
    Givner, Laurence B.
    Hoffman, Jill A.
    Bradley, John S.
    Hulten, Kristina G.
    Mason, Edward O.
    Kaplan, Sheldon L.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (01)
  • [46] Impact of pneumococcal conjugate vaccines on invasive pneumococcal disease-causing lineages among South African children
    Lekhuleni, Cebile
    Ndlangisa, Kedibone
    Gladstone, Rebecca A.
    Chochua, Sopio
    Metcalf, Benjamin J.
    Li, Yuan
    Kleynhans, Jackie
    de Gouveia, Linda
    Hazelhurst, Scott
    Ferreira, Ana D. S.
    Skosana, Happy
    Walaza, Sibongile
    Quan, Vanessa
    Meiring, Susan
    Hawkins, Paulina A.
    Mcgee, Lesley
    Bentley, Stephen D.
    Cohen, Cheryl
    Lo, Stephanie W.
    von Gottberg, Anne
    du Plessis, Mignon
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [47] Invasive pneumococcal disease in children and adults in seven Italian regions after the introduction of the conjugate vaccine, 2008-2014
    D'Ancona, Fortunato
    Caporali, Maria Grazia
    Del Manso, Martina
    Giambi, Cristina
    Camilli, Romina
    D'Ambrosio, Fabio
    Del Grosso, Maria
    Iannazzo, Stefania
    Rizzuto, Elvira
    Pantosti, Annalisa
    EPIDEMIOLOGIA & PREVENZIONE, 2015, 39 (04): : 134 - 138
  • [48] Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine: Comparison With the Era Before 7-valent Conjugate Vaccine
    Sharma, Dolly
    Baughman, Wendy
    Holst, Amy
    Thomas, Stephanie
    Jackson, Delois
    Carvalho, Maria da Gloria
    Beall, Bernard
    Satola, Sarah
    Jerris, Robert
    Jain, Shabnam
    Farley, Monica M.
    Nuorti, J. Pekka
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) : E45 - E53
  • [49] Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco
    Diawara, Idrissa
    Zerouali, Khalid
    Katfy, Khalid
    Zaki, Bahija
    Belabbes, Houria
    Najib, Jillali
    Elmdaghri, Naima
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2015, 40 : 95 - 101
  • [50] Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010-2016
    Makwana, Ashley
    Sheppard, Carmen
    Borrow, Ray
    Fry, Norman
    Andrews, Nick J.
    Ladhani, Shamez N.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2018, 37 (07) : 697 - 703